New combination therapies targeting lipid and glutamine metabolism for glioblastoma
Novel lipid and glutamine metabolism-based combination therapies for glioblastoma
This study is looking at new ways to treat glioblastoma, a tough brain tumor, by testing a drug called pimozide that might help stop the tumor from growing by cutting off its food supply, and so far, it’s showing good results in animals without causing major side effects.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-11070872 on NIH RePORTER |
What this research studies
This research investigates innovative therapies for glioblastoma, a highly aggressive brain tumor. It focuses on how glioblastoma cells utilize lipids and glutamine for growth and explores the potential of a drug called pimozide, which inhibits lysosomal function, to disrupt this process. By blocking the supply of essential lipids and glutamine, the research aims to effectively reduce tumor growth. Initial tests in animal models have shown promising results without significant side effects.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with glioblastoma who are seeking new treatment options.
Not a fit: Patients with other types of brain tumors or those who are not diagnosed with glioblastoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment options for patients with glioblastoma, potentially improving survival rates.
How similar studies have performed: Other research has shown success in targeting metabolic pathways in cancer treatment, suggesting that this approach may also be effective for glioblastoma.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Guo, Deliang — Ohio State University
- Study coordinator: Guo, Deliang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.